Q3 FY25 Quarterly Investor Presentation & Webinar
Filed with ASX · · 49 pages · English
Watch Microba Life Sciences' latest callMicroba Life Sciences (ASX:MAP) Q4 2025 Earnings Call · Replay · Jul 22, 2025Read the transcript of Microba Life Sciences (ASX:MAP) Q4 2025 Earnings CallPresenting: CEO, Dr Luke Reid Webinar Access: The Quarterly Investor Presentation Video can now be accessed on demand via Microba’s Investor Hub at the following link Q3 FY25 Quarterly Investor Video Presentation Investor Q&As We invite investors and interested parties to submit questions on the Quarterly Investor Presentation & Webinar through the ‘Ask a question’ section of Microba’s interactive
Microba Life Sciences Limited on 6ix
In the deck
Story so far
Earlier from Microba Life Sciences
- Q3 FY25 Quarterly Activities Report & Appendix 4C
- Microba Delivers Landmark IBD Results & Signs Major Gastro Partner
- Appendix 4D & FY25 Interim Report
- Q2 FY25 Quarterly Investor Presentation & Webinar
- Q2 FY25 Quarterly Activities Report & Appendix 4C
Later from Microba Life Sciences
- Landmark GI Study Results from over 4,600 patients
- Microba Announces Landmark GI Study Results From Over 4,600 Patients
- MetaPanel Pathogen Study Delivers Breakthrough Results
- Trading Halt
- Suspension from Quotation
Follow Microba Life Sciences into a list and get an email when it puts out news.
Follow Microba Life Sciences